Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Asset Utilization Ratio (2022 - 2025)

Historic Asset Utilization Ratio for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to 0.6.

  • Phathom Pharmaceuticals' Asset Utilization Ratio rose 70692.7% to 0.6 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.6, marking a year-over-year increase of 70692.7%. This contributed to the annual value of 0.14 for FY2024, which is 581790.76% up from last year.
  • Phathom Pharmaceuticals' Asset Utilization Ratio amounted to 0.6 in Q3 2025, which was up 70692.7% from 0.42 recorded in Q2 2025.
  • Phathom Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.6 for Q3 2025, and its period low was 0.16 during Q1 2023.
  • Over the past 4 years, Phathom Pharmaceuticals' median Asset Utilization Ratio value was 0.02 (recorded in 2024), while the average stood at 0.09.
  • In the last 5 years, Phathom Pharmaceuticals' Asset Utilization Ratio surged by 10140.74% in 2023 and then skyrocketed by 678917.1% in 2024.
  • Phathom Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.15 in 2022, then surged by 101.41% to 0.0 in 2023, then surged by 6789.17% to 0.14 in 2024, then surged by 315.67% to 0.6 in 2025.
  • Its last three reported values are 0.6 in Q3 2025, 0.42 for Q2 2025, and 0.24 during Q1 2025.